Event ContactsPaid membership required to see this information
The health care delivery system continues to evolve to provide ever-enhanced value to patients. This requires a shift in regulatory science, tools, realities, and perceptions of biopharmaceutical product benefit-risk across the global pharmacovigilance landscape. It is more important than ever to find ways to fully harness innovation and adopt new technologies to advance pharmacovigilance practices. During this three-day meeting, thought leaders from around the world will provide their insights and engage in dialogue on current and potential new opportunities, operational challenges, and practical aspects, as well as demands in managing product risk in the context of benefits, in the ever-changing world of medical product safety, pharmacovigilance, and global regulations.
This event will provide an unique opportunity for dialogue with representatives from FDA and other key regulatory agencies, as well as from industry and academia. There will be multiple opportunities for participants to engage with speakers and interact with colleagues.
Global Regulatory Safety Updates
New Data Sources for Safety Assessment
Current Approaches to Benefit-Risk Assessment
Luncheon Roundtable Discussions with Key Thought Leaders
Tabletop Exhibits and Networking Opportunities
Reach Your Audience
At DIA conferences, medical product developers, regulators, academics, and patient advocates all come together in one place, eager to receive fresh insight and share new information. DIA conferences are the perfect place for you to communicate your key messages to an influential audience, efficiently and cost effectively.
We are also excited to offer additional marketing opportunities to reach meeting participants, including a premeeting eBlast to registered attendees, social media bundle to drive awareness of your products/services and attendance through DIA’s social media channels and promoted posts on the DIA Global App, plus more.
For more than 50 years, DIA (the Drug Information Association) has served as a global forum for all those involved in health care product development and life cycle management to exchange knowledge and collaborate in a neutral setting. DIA is an essential resource that provides opportunities to extend debate and discussion to advance scientific and medical innovation.
There may be many networking opportunities at the DIA Pharmacovigilance and Risk Management Strategies 2017 - Drug Information Association. Find out more in the event details below.
|Conference/Event Dates:||01/23/2017 - 01/25/2017|
|Primary Industry:||Clinical Pharmacology|
|Other Industries:||Associations, Clinical Pharmacology, Pharmaceutical, Professional Healthcare|
|Audience:||Intermediate to Advanced Clinical Safety Professionals who are involved in:
Risk Management, including Risk Evaluation and Mitigation Strategies (REMS)
Medical Product Safety Assessment
Customer Engagement Programs, including Patient Support Programs
It is also designed for professionals who work for:
Industry: Pharmaceuticals and Biologics
Clinical Research Organizations (CROs)
Academic Research Centers
|Venue:||Mandarin Oriental Washington D.C.|
|Venue Phone:||(202) 554-8588|
|Venue Type:||Indoor - Hotel|
|Official Conference Hotel:||Mandarin Oriental Washington D.C.|
|Conference Hotel URL:||http://www.mandarinoriental.com/washington/...|
|Number of Exhibitors:||20+ (2016) (Previous Year)|
|Show Owner:||Drug Information Association (DIA)|
|Booth Size||Booth Cost||Available Amenities|
|Tabletop||$1,500 / Price is subject to change.||Electricity:||Yes||- Unknown Price|
|Marketing Vehicles Allowed:||Call|
|Other Booth Sizes Available: n/a|
How do I show up here?
Add a note here, it is only visible by you.
2016 Floorplan & Exhibitor List: